| Product Code: ETC12838341 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Influenza B Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Influenza B Market Revenues & Volume, 2021 & 2031F |
3.3 China Influenza B Market - Industry Life Cycle |
3.4 China Influenza B Market - Porter's Five Forces |
3.5 China Influenza B Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 China Influenza B Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 China Influenza B Market Revenues & Volume Share, By Patient Age Group, 2021 & 2031F |
3.8 China Influenza B Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Influenza B Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of flu vaccination in China |
4.2.2 Growing adoption of preventive healthcare measures among the population |
4.2.3 Rising government initiatives to control and prevent the spread of influenza B |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in rural areas of China |
4.3.2 High cost associated with influenza B treatment and vaccination |
4.3.3 Presence of counterfeit or substandard influenza vaccines in the market |
5 China Influenza B Market Trends |
6 China Influenza B Market, By Types |
6.1 China Influenza B Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 China Influenza B Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 China Influenza B Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Baloxavir), 2021 - 2031F |
6.1.4 China Influenza B Market Revenues & Volume, By Symptom Management (Pain Relievers, Antihistamines), 2021 - 2031F |
6.2 China Influenza B Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 China Influenza B Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 China Influenza B Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.2.4 China Influenza B Market Revenues & Volume, By Inhalation, 2021 - 2031F |
6.3 China Influenza B Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 China Influenza B Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 China Influenza B Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 China Influenza B Market Revenues & Volume, By Geriatric, 2021 - 2031F |
6.4 China Influenza B Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 China Influenza B Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.3 China Influenza B Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 China Influenza B Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 China Influenza B Market Import-Export Trade Statistics |
7.1 China Influenza B Market Export to Major Countries |
7.2 China Influenza B Market Imports from Major Countries |
8 China Influenza B Market Key Performance Indicators |
8.1 Percentage increase in influenza B vaccination coverage among the population |
8.2 Number of government-sponsored influenza prevention programs implemented |
8.3 Rate of reported influenza B cases compared to previous years |
9 China Influenza B Market - Opportunity Assessment |
9.1 China Influenza B Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 China Influenza B Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 China Influenza B Market Opportunity Assessment, By Patient Age Group, 2021 & 2031F |
9.4 China Influenza B Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Influenza B Market - Competitive Landscape |
10.1 China Influenza B Market Revenue Share, By Companies, 2024 |
10.2 China Influenza B Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here